After more than a decade of deep cultivation, the IP Forefront Pharma Forum (IFPF) has grown into the most influential and forward-looking annual event in the field of pharmaIP in China and even globally. On September 16-18, 2026, we will once again welcome the 11th IFPF in Shanghai, under the theme “Innovation • Protection • Globalization – A New Ecosystem for Pharmaceutical IP”. During 2025-2026, China’s pharma IP system is undergoing intensive changes: the revision of the Implementing Regulations of the Drug Administration Law, and the deep implementation of patent term compensation and test data protection. At the same time, the total value of Chinese innovative drugs going global has exceeded 100 billion US dollars, the NewCo model is moving from “deal signing” to “going public”, and IP competition in cutting-edge fields such as AI-driven drug discovery, conjugated drugs (ADCs/RDCs), and cell therapy is intensifying. IFPF 2026 will bring together global industry wisdom to jointly explore the paths for pharmaceutical IP protection and commercialization in this new ecosystem.
IFIF 2026 will help you understand
• Observation and Development of Drug PTE and Test Data Protection
• Frontiers and Challenges of Second Medical Use Patent Protection
• New IP Landscape of Conjugate Drugs (ADC/RDC/Small Nucleic Acid)
• Golden Window for Biosimilar Going Global (Patent Expiry Wave 2025–2034)
• Definition of the Scope of Protection of Crystalline Patent Claims (Divergence Between the Indobufen Case and the Topiroxostat Case)
• Comparison of Pharma Patent Equivalent Infringement from the Perspective of Sino‑US Judicial Practice
• Administrative Adjudication and Judicial Litigation in the Early Resolution Mechanism of Pharma Patent Disputes
• Indepth Comparison of Pharma Patent Examination and Grant Standards in China, the US and Europe
• Hot Issues in US Patent Drafting and Prosecution–New Trends in Pharma Patent Drafting, Examination and Reexamination
• Situation of Pharma Cases Before the Unified Patent Court (UPC)
• Amendments to the New Edition of the EPC Guidelines for Examination and Suggestions for Patent Drafting
• IP Challenges and Responses in AI-Driven Drug Discovery, and IP System Construction Under MNC Thinking
Benefits of Attending
• Unique opportunity to raise your profile and showcase your expertise of your organization in Pharma IP area
• Enhancing and establish your partnerships with In-house counsel and industry peers globally to protect your patents and market exclusivity
• Catch up the global pharma IP landscape and trends to build your strategies to adapt it
• Exploring the opportunities of China’s pharmaceutical market and its impact on global innovation system
• Branding your IP services by in-depth conversation,speaking and exhibition booth in front of global pharma IP professionals throughout this three days pharma IP focused summit
• Getting Insights from leading in-house IP counsel, patent prosecutors and litigators, government officials and policy experts from around the world on latest and hottest pharma IP issues facing IP professions today
• Arranging meetings with participants during the conference (Pre-Conference workshops, Tea break, Cocktail parties and Lunches )by using IFPF 2023 online networking system
